קלופיד 75 מ"ג

Држава: Израел

Језик: Хебрејски

Извор: Ministry of Health

Активни састојак:

CLOPIDOGREL 75 MG

Доступно од:

TARO INTERNATIONAL LTD

АТЦ код:

B01AC04

Фармацеутски облик:

FILM COATED TABLETS

Пут администрације:

PER OS

Произведен од:

PHARMATHEN S.A., GREECE

Терапеутска група:

CLOPIDOGREL

Терапеутске индикације:

Clopidogrel is indicated in adults for the prevention of atherothrombotic events as follows:Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.Patients suffering from Acute Coronary Syndrome- Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave myocardial infarction (MI)), including patients undergoing a stent replacement following percutaneous coronary intervention, in combination with acetylsalicylic acid (ASA). - ST segment elevation acute myocardial infarction, in combination with ASA in medically treated patients eligible for thrombolytic therapy

Датум одобрења:

2011-06-01